CHAIRMAN

Prof. Manel Esteller

Prof. Manel Esteller

Josep Carreras Leukaemia Research Institute (IJC), Spain

STEERING COMMITTEE 

Prof. Ann K. Daly

Prof. Ann K. Daly

University Medical School, United Kingdom

Prof. Matthias Schwab

Prof. Matthias Schwab

IKP and Dept of Clinical Pharmacology, Univ Hospital of Tuebingen, Germany

Prof. Anne-Marie Caminade

Prof. Anne-Marie Caminade

Coordination Chemistry Lab of Toulouse and University of Toulouse, France

SCIENTIFIC COMMITTEE

The PEMED 2020 Scientific Committee is composed of the key speakers and the chair committee. They are in charge of assessing the submitted papers based on the peer review method.

Dr. Adrian Llerena

Dr. Adrian Llerena

Extremadura University, Spain

Dr. Ann Daly

Dr. Ann Daly

Newcastle University, United Kingdom

Dr. German Ott

Dr. German Ott

Department of Clinical Pathology Robert-Bosch-Krankenhaus Stuttgart, Germany

Dr. Jan Trost Jorgensen

Dr. Jan Trost Jorgensen

Dx-Rx Institute, Denmark

Dr. Philippe Pinton

Dr. Philippe Pinton

Takeda Pharmaceutical Company Limited, Japan

Dr. Ursula Amstutz

Dr. Ursula Amstutz

Inselspital Bern University Hospital, Switzerland

Dr. Volker Lauschke

Dr. Volker Lauschke

Karolinska Instutet, Sweden

Dr. Masaru Katoh

Dr. Masaru Katoh

National Cancer Center, Japan

Dr. Wang Yu

Dr. Wang Yu

The University of Hong Kong, Hong Kong